Immuron Ltd (IMRN) 6-K, filed Nov 25, 2020

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE13a-16 OR 15d-16

UNDER THE SECURITIESEXCHANGE ACT OF 1934

For the Month of November 2020

Commission File Number: 001-38104

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, CarltonSouth, Victoria, 3053, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

IMMURON LIMITED

EXPLANATORY NOTE

Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on November 25, 2020 titled:

-	“Change of Director's Interest Notice (DP)”

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

EXHIBITS

Exhibit<br><br>Number	Description
99.1	Change of Director's Interest Notice (DP)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMURON LIMITED
Date: November 25, 2020	By:	/s/ Phillip Hains
		Phillip Hains
		Company Secretary

Exhibit99.1

Appendix3Y

Changeof Director’s Interest Notice

Rule3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.	Amended 01/01/11

**<br><br> <br>Name of Entity:**	Immuron<br> Limited (ASX: IMC)
ABN:	80<br> 063 114 045

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name<br> of Director:	Daniel<br> Pollock
Date of Last Notice:	17<br> November 2020

Part1 - Change of director’s relevant interests in securities

Inthe case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

**<br><br> <br>Direct or Indirect Interest**	Direct
Nature of indirect interest<br><br> <br>(including registered holder)<br><br> <br>Note:<br> Provide details of the circumstances giving rise to the relevant interest.	-
Date of change	20 November 2020
No. of securities held prior to change		Shares	Options
	Direct	693,550*	1,800,000
	Indirect	174,480	-
	Total	868,030	1,800,000
	* Securities include American Depository Securities (ADSs).
Class	Fully paid ordinary shares
---	---
Number acquired		Shares	Options
---	---	---	---
	Direct	-	-
	Indirect	-	-
	Total	-	-
Number disposed		Shares	Options
---	---	---	---
	Direct	100,000	-
	Indirect	-	-
	Total	100,000	-
+ See chapter 19 for defined terms.
---	---
01/01/2011	Appendix 3Y Page 1

Appendix3Y

Changeof Director’s Interest Notice

Value/Consideration<br><br> <br>Note:<br> If consideration is non-cash, provide details and estimated valuation	A0.26 per share.
No. of securities held after change		Options
	Direct	1,800,000
	Indirect	-
	Total	1,800,000
	* Securities include American Depository Securities (ADSs).
Nature of change<br><br> <br>Example:<br> On-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in<br> buy-back	On-market trade.

All values are in US Dollars.

Part2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder<br><br> <br>(if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change<br><br> <br>Note:<br> Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration<br><br> <br>Note:<br> If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

The CFO Solution

+ See chapter 19 for defined terms.
01/01/2011	Appendix 3Y Page 2

Immuron Ltd 6-K, filed Nov 25, 2020

About this 6-K